Synthesis, Molecular Modelling and Antibacterial Activity Against Helicobacter pylori of Novel Diflunisal Derivatives as Urease Enzyme Inhibitors

Author(s): Göknil Pelin Coşkun, Teodora Djikic, Sadık Kalaycı, Kemal Yelekçi, Fikrettin Şahin, Ş. Güniz Küçükgüzel*.

Journal Name: Letters in Drug Design & Discovery

Volume 16 , Issue 4 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: The main factor for the prolongation of the ulcer treatment in the gastrointestinal system would be Helicobacter pylori infection, which can possibly lead to gastrointestinal cancer. Triple therapy is the treatment of choice by today's standards. However, observed resistance among the bacterial strains can make the situation even worse. Therefore, there is a need to discover new targeted antibacterial therapy in order to make success in the eradication of H. pylori infections.

Methods: The targeted therapy rule is to identify the related macromolecules that are responsible for the survival of the bacteria. Thus, 2-[(2',4'-difluoro-4-hydroxybiphenyl-3-yl)carbonyl]-N- (substituted)hydrazinocarbothioamide (3-13) and 5-(2',4'-difluoro-4-hydroxybiphenyl-3-yl)-4- (substituted)-2,4-dihydro-3H-1,2,4-triazole-3-thiones (14-17) were synthesized and evaluated for antibacterial activity in vitro against H. pylori.

Results: All of the tested compounds showed remarkable antibacterial activity compared to the standard drugs (Ornidazole, Metronidazole, Nitrimidazin and Clarithromycin). Compounds 4 and 13 showed activity as 2µg/ml MIC value.

Conclusion: In addition, we have investigated binding modes and energy of the compounds 4 and 13 on urease enzyme active by using the molecular docking tools.

Keywords: Diflunisal, Helicobacter pylori, molecular docking, thiosemicarbazide, 1, 2, 4-triazole-3-thiones, macromolecules.

[1]
Ness-Jensen, E.; Lagergren, J. Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease. Best Pract. Res. Clin. Gastroenterol., 2017, 31(5), 501-508.
[2]
Chen, X.; Li, P.; Wang, F.; Ji, G.; Miao, L.; You, S. Psychological results of 438 patients with persisting gastroesophageal reflux disease symptoms by symptom checklist 90-revised questionnaire. Euroasian J. Hepatogastroenterol, 2017, 7(2), 117-121.
[3]
Li, N.; Cao, M.; Yi, S.; Cheng, J.; Wang, L.; Tao, Y.; Wu, D.; Peng, J.; Zhang, M.; Qi, P.; Zhao, J. Effects of the RNA-binding protein, KSRP, on innate immune response against Helicobacter pylori infection in mice. Biochem. Biophys. Res. Commun., 2017, 17, 32401-32404.
[4]
Ma, J.; Hiratsuka, T.; Etoh, T.; Akada, J.; Fujishima, H.; Shiraishi, N.; Yamaoka, Y.; Inomata, M. Anti-proliferation effect of blue light-emitting diodes against antibiotic-resistant Helicobacter pylori. J. Gastroenterol. Hepatol., 2017, 33(8), 1492-1499.
[5]
Preda, C.M.; Proca, D.; Sandra, I.; Fulger, L.E.; Horeanga, B.C.; Manuc, M.; Manuc, T.; Dute, C.A.; Barbu, M.; Tugui, L.; Andrei, A.C.; Slavulete, B.I.; Diculescu, M. A comparative study of efficacy and safety of two eradication regimens for helicobacter pylori infection. Maedica (Buchar.), 2017, 12(3), 157-163.
[6]
Kao, C.Y.; Sheu, B.S.; Wu, J.J. Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis. Biomed. J., 2016, 39, 14-23.
[7]
Ruiter, R.; Wunderink, H.F.; Veenendaal, R.A.; Visser, L.G.; Boer, M.G.J. Helicobacter pylori resistance in the Netherlands: A growing problem? Neth. J. Med., 2017, 75(9), 394-398.
[8]
Phull, A.R.; Hassan, M.; Abbas, Q.; Raza, H.; Haq, I.U.; Seo, S.Y.; Kim, S.J. In-vitro, in silico elucidation of antiurease activity, kinetic mechanism and COX-2 inhibitory efficacy of Coagulansin-A of Withania coagulans. Chem. Biodivers., 2017, 15(1), e1700427.
[9]
Schwartz, J.T.; Allen, L.A. Role of urease in megasome formation and Helicobacter pylori survival in macrophages. J. Leukoc. Biol., 2006, 79, 1214-1225.
[10]
Eaton, K.A.; Brooks, C.L.; Morgan, D.R.; Krakowka, S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun., 1991, 59, 2470-2475.
[11]
Schoep, T.D.; Fulurija, A.; Good, F.; Lu, W.; Himbeck, R.P.; Schwan, C. Surface properties of Helicobacter pylori urease complex are essential for persistence. PLoS One, 2010, 5, 15-42.
[12]
Campanale, M.; Nucera, E.; Ojetti, V.; Cesario, V.; Di Rienzo, T.A.; D’Angelo, G. Nickel free-diet enhances the Helicobacter pylori eradication rate: A pilot study. Dig. Dis. Sci., 2014, 59, 1851-1855.
[13]
Stéphane, L.; Benoit, A.L. Zbell, Robert, J. Maier. Nickel enzyme maturation in Helicobacter hepaticus: Roles of accessory proteins in hydrogenase and urease activities. Microbiology, 2007, 153(Pt 11), 3748-3756.
[14]
Olson, J.W.; Mehta, N.S.; Maier, R.J. Requirement of nickel metabolism proteins HypA and HypB for full activity of both hydrogenase and urease in Helicobacter pylori. Mol. Microbiol., 2001, 39(1), 176-182.
[15]
Taha, M.; Ismail, N.H.; Imran, S.; Wadood, A.; Rahim, F.; Khan, K.M.; Riaz, M. Hybrid benzothiazole analogs as antiurease agent: Synthesis and molecular docking studies. Bioorg. Chem., 2016, 66, 80-87.
[16]
Upadhyay, L.S.B. Urease inhibitors: A review. Indian J. Biotechnol., 2012, 11, 381-388.
[17]
Abid, O.U.R.; Babar, T.M.; Ali, F.I. Identification of novel urease inhibitors by high-throughput virtual and in vitro screening. ACS Med. Chem. Lett., 2010, 1(4), 145-149.
[18]
Serwar, M.; Akhtar, T.; Hameed, S.; Khan, K. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1,2,4-triazole-3(4H)-thiones. ARKIVOC, 2009, 7, 210-221.
[19]
Küçükgüzel, Ş.G.; Mazi, A.; Sahin, F.; Öztürk, S.; Stables, J. Synthesis and biological activities of diflunisal hydrazide-hydrazones. Eur. J. Med. Chem., 2003, 38, 1005-1013.
[20]
Kalaycı, S.; Demirci, S.; Sahin, F. Antimicrobial properties of various psychotropic drugs against broad range microorganisms. Curr. Psychopharmacol., 2014, 3(3), 195-202.
[21]
Huang, J.; Zhou, J.; Song, S.; Song, H.; Chen, Z.; Yi, W. A new and efficient ZnCl2-catalyzed synthesis and biological evaluation of novel 2-amino-3,5-dicyano-4-aryl-6-aryl-aminopyridines as potent antibacterial agents against Helicobacter Pylori (HP). Tetrahedron, 2015, 8628-8636.
[22]
Küçükgüzel, Ş.G.; Kocatepe, A.; Clercq, E.D.; Şahin, F.; Güllüce, M. Synthesis and biological activity of 4-thiazolidinones, thiosemicarbazides derived from diflunisal hydrazide. Eur. J. Med. Chem., 2006, 41, 353-359.
[23]
Küçükgüzel, Ş.G.; Küçükgüzel, İ.; Tatar, E.; Rollas, S.; Şahin, F.; Güllüce, M. Clercq, Erik De; Kabasakal, L. Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. Eur. J. Med. Chem., 2007, 42, 893-901.
[24]
Khan, I.; Ali, S.; Hameed, S.; Rama, N.H.; Hussain, M.T.; Wadood, A.; Uddin, R.; Ul-Haq, Z.; Khan, A.; Ali, S.; Choudhary, M.I. Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Eur. J. Med. Chem., 2010, 45, 5200-5207.


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 16
ISSUE: 4
Year: 2019
Page: [392 - 400]
Pages: 9
DOI: 10.2174/1570180815666180627130208
Price: $58

Article Metrics

PDF: 28
HTML: 1